Oral anticoagulant treatment in children based on monitoring at home

被引:17
作者
Mähönen, S
Riikonen, P
Väätäinen, RL
Tikanoja, T
机构
[1] Univ Kuopio, Dept Paediat, FIN-70211 Kuopio, Finland
[2] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
anticoagulation; children; home monitoring;
D O I
10.1080/08035250410025726
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To evaluate the feasibility of home monitoring of oral anticoagulant treatment (OAT) in paediatric patients. Methods: A total of 19 paediatric patients received OAT and then monitored their treatment at home with CoaguChek(R). Data on their International Normalized Ratio (INR) values were collected retrospectively from hospital records and from the notes kept by the families. The families of the patients were also asked to fill in a questionnaire. Results: No thrombotic or haemorrhagic complications occurred during a total amount of 44.7 follow-up years. INR: the proportion of INR values measured at home falling within the therapeutic range for the given patient varied from 33 to 86% (median 69%). The questionnaire: all respondents were satisfied with home monitoring, and 63% felt that a major advantage of home monitoring was that there was no need to perform venipuncture. While 47% of the respondents reported no disadvantages of home monitoring, 42% reported that they occasionally lacked confidence in their ability to conduct OAT correctly at home. Conclusion: Home monitoring of OAT is feasible and reasonably reliable in paediatric patients. However, it is crucial that healthcare professionals supervise the treatment and the families are provided with detailed and precise instructions on how to act in a variety of clinical situations.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 13 条
[1]  
ANDREW M, 1994, THROMB HAEMOSTASIS, V71, P265
[2]   Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer [J].
Attermann, J ;
Kynde, K ;
Hasenkam, JM .
THROMBOSIS RESEARCH, 1998, 92 (06) :287-291
[3]  
Christensen TD, 2001, SCAND CARDIOVASC J, V35, P107
[4]   Self-management of oral anticoagulation in children with congenital heart disease [J].
Christensen, TD ;
Attermann, J ;
Hjortdal, VE ;
Maegaard, M ;
Hasenkam, JM .
CARDIOLOGY IN THE YOUNG, 2001, 11 (03) :269-276
[5]   Oral anticoagulation self-management and management by a specialist anticoagulation clinic:: a randomised cross-over comparison [J].
Cromheecke, ME ;
Levi, M ;
Colly, LP ;
de Mol, BJM ;
Prins, MH ;
Hutten, BA ;
Mak, R ;
Keyzers, KCJ ;
Büller, HR .
LANCET, 2000, 356 (9224) :97-102
[6]  
CUMMINGS SR, 2001, DESIGNING CLIN RES
[7]  
Ezekowitz MD, 2002, J HEART VALVE DIS, V11, pS56
[8]   Standardization of prothrombin time for laboratory control of oral anticoagulant therapy [J].
Kitchen, S ;
Preston, FE .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01) :17-25
[9]  
LOELIGER EA, 1985, THROMB HAEMOSTASIS, V53, P155
[10]   Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting [J].
Marzinotto, V ;
Monagle, P ;
Chan, A ;
Adams, M ;
Massicotte, P ;
Leaker, M ;
Andrew, M .
PEDIATRIC CARDIOLOGY, 2000, 21 (04) :347-352